KOLBRAFNO Trademark

Trademark Overview

On Monday, June 23, 2014, a trademark application was filed for KOLBRAFNO with the United States Patent and Trademark Office. The USPTO has given the KOLBRAFNO trademark a serial number of 86317553. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by Glaxo Group Limited. The KOLBRAFNO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kolbrafno

General Information

Serial Number86317553
Word MarkKOLBRAFNO
Filing DateMonday, June 23, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number5293652
Registration DateTuesday, September 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Thursday, June 26, 2014NEW APPLICATION ENTERED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Monday, June 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 29, 2014ASSIGNED TO EXAMINER
Monday, September 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 11, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 1, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 1, 2015SOU EXTENSION 1 FILED
Wednesday, December 9, 2015SOU TEAS EXTENSION RECEIVED
Monday, January 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 18, 2016SOU EXTENSION 3 GRANTED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2015SOU EXTENSION 2 FILED
Tuesday, January 26, 2016SOU EXTENSION 2 GRANTED
Wednesday, January 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 29, 2016SOU EXTENSION 3 FILED
Thursday, June 15, 2017NOTICE OF ALLOWANCE CANCELLED
Thursday, June 15, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, September 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2016SOU EXTENSION 4 FILED
Tuesday, December 13, 2016SOU EXTENSION 4 GRANTED
Wednesday, December 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 21, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, September 26, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 5, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

kolbrafno pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological